Neuroethics
News and analysis on the implications of brain science
by Arielle Baskin-Sommers
Aeon | July 18, 2017
There is now substantial evidence that psychopaths can in fact experience emotions – but only under the right circumstances.
|
 |
by Monique Wonderly
International Neuroethics Society | July 13, 2017
Each year the International Neuroethics Society (INS) holds a Student/Postdoc Essay Contest. One of the 2016 winners is by Monique Wonderly, postdoc at Princeton University Center for Human Values.
|
 |
by Kaitlyn McGlothlen
International Neuroethics Society | July 10, 2017
Each year the International Neuroethics Society (INS) holds a Student/Postdoc Essay Contest. One of the 2016 winners is by Kaitlyn McGlothlen, University of Washington, departments of philosophy and psychology.
|
by Mo Costandi
Dana Foundation | July 3, 2017
Drugs that enhance cognition might benefit people who have cognitive troubles due to depression or schizophrenia, said researcher Barbara Sahakian in a recent lecture at University College London. While there are suggestions that modafinil could improve cognitive performance in high-risk sleep-deprived people, it is less clear whether any benefit would outweigh risks and side effects for people in the normal course of life.
|
by Michael Slepian
Quartz | June 21, 2017
Even when we are not actively hiding a secret, it can still hurt us, and so finding more productive ways to think about the secret may go a long way toward improving well-being.
|
by Neil Levy
The Neuroethics Blog | June 20, 2017
The research that shows us how people may be fooled by false claims also provides guidance as to how to make people more responsive to good evidence. We could utilize this information to design informational nudges, with the aim of ensuring that people are better informed.
|
by Barbara Bradley Hagerty
The Atlantic | June 1, 2017
The condition has long been considered untreatable. Experts can spot it in a child as young as 3 or 4. But a new, intensive, clinical approach offers hope.
|
by Christopher Markou
The Conversation | May 16, 2017
In a recent US court case, a man was sentenced to six years in prison at least in part by the recommendation of a private company’s secret proprietary software.
|
by Casey Schwartz
New York Times | May 6, 2017
For the advocates gathered for the convention of the Multidisciplinary Association for Psychedelic Studies (MAPS), that psychedelic drugs, from LSD to magic mushrooms to MDMA (also known as Ecstasy or Molly), are taking a place in mainstream life. “We are not the counterculture,” said Rick Doblin, the executive director of MAPS, “we are the culture.”
|
by Neuroskeptic
Discover Magazine | April 29, 2017
Do we have a human right to the privacy of our brain activity? Is “cognitive liberty” the foundation of all freedom? An interesting new paper by Swiss researchers Marcello Ienca and Roberto Andorno explores such questions.
|
by Jules Montague
Aeon | April 17, 2017
It’s not just those with brain injury or the very young who are susceptible to confabulation. Being tricked into confabulation and hence into a doubt deficit, even without brain injury, has moral and ethical consequences.
|
by Olga Khazan
The Atlantic | April 11, 2017
Poverty tends to dampen test scores, but new research suggests people with hard upbringings can sometimes outperform their more-privileged peers. "We’re not arguing that stress is good. We’re arguing that’s real, and that’s half the story," says one researcher.
|
Page: 1 of 8
